MedTrace Logo

A Study Comparing the Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris

NCT02535871 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 800

Last updated 2015-09-14

No results posted yet for this study

Summary

The primary objective of this study is to compare the efficacy, safety and tolerability of IDP-121 Lotion and vehicle in the treatment of subjects with acne vulgaris.

Conditions

  • Acne Vulgaris

Interventions

DRUG

IDP-121 Lotion

Investigational Product: IDP-121 Lotion

DRUG

IDP-121 Vehicle Lotion

Comparator Product: IDP-121 Vehicle Lotion

Sponsors & Collaborators

  • Valeant Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Anya Loncaric, MS · Valeant Pharmaceuticals

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
9 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2016-07-31
Completion
2016-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02535871 on ClinicalTrials.gov